The history of London, England’s laboratory product exhibitions is long and varied. There used to be a very successful lab exhibition and scientific conference in London called The British Laboratory Week, or Lab Week for short (fancy that, a whole week). Some 20 years ago, a competing event was launched and the British lab scene […]
Held for the second consecutive year in the heart of US oil country, this year’s ISA exposition in Houston, Texas, met many people’s lowered expectations for the event. Many process analytical instrument vendors opted for smaller booths and some elected to pass up the show altogether. Although attendance and number of exhibitors declined 4% and […]
Last month, Novartis and the Massachusetts Institute of Technology (MIT) announced the formation of a research partnership dedicated to continuous manufacturing. Novartis will give MIT $65 million over the next 10 years to establish the program; according to The Boston Globe, $40 million of this funding will come in the first five years. The Novartis-MIT […]
It has been three years since 10 countries—Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovakia and Slovenia—joined the EU (EU 10), adding 5% to the GDP of the world’s largest economy. In January, Bulgaria and Romania also became members the EU. EU membership has strengthened new member states’ (NMS) trade status, financial stability […]
AOAC International held its annual meeting and exposition from September 16 to 20 at the Hyatt Regency in Anaheim, California. The meeting’s return to California after a five-year absence appeared to have increased attendance. The AOAC reported 845 registered attendees, up from just over 800 last year, including about 230 international attendees. A number of […]
In the August 31 issue, IBO reported that Chris van Ingen, president of Agilent’s Bio-Analytical Measurement (BAM)/Life Science and Chemical Analysis business, will retire in October and would not be replaced. At the unit’s September 13 presentation to investors, Agilent CEO Bill Sullivan presented a new corporate reporting structure. Six business unit heads will now […]
Due to the inclusion of the International Sales Index in last month’s issue, IBO was unable to publish the results of the Life Science Sales Index for the second quarter. Here we present the results for that Index, as well as quarterly financial information for Index companies that not been covered in a previous issue. […]
The construction of new laboratories is growing in Asia, driven by government funding (see page 7) and manufacturing and R&D investment from the West. China’s Ministry of Science and Technology alone has approved the construction of 27 “national key laboratories” this year. China’s Ministry of Commerce reported this month that over 1,000 R&D centers have […]
For companies in the instrument industry, protecting patents is a crucial aspect of business. As was the case in last year’s article (see IBO 11/30/06), Bio-Rad, Applied Biosystems and Invitrogen continue to be among the most legally aggressive companies. First, to begin on a positive note, Bio-Rad’s suit against 4titude and Phenix Research Products was […]
On September 18, on the heels of a market correction, the Federal Reserve cut the Fed funds rate by a surprising half-point to 4.75%, sending the Dow, S&P 500 and NASDAQ up 2.5%, 2.9% and 2.7%, respectively. Signs of a slowing economy incited by the declining housing market apparently swayed the Fed to take drastic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
